One page, thousands of outlets. See who else covered it.
We haven't written up this one. The Indian Express - Lifestyle has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
APJUDA cuts its demand from a 30% biennial revision to 20%, rejects the government’s 3% offer as inadequate, and seeks a hearing before the Chief Minister as the strike enters its tenth day
National Research and Innovation Agency (BRIN) researcher Ristiyanto emphasized that patterns of disease intervention ...
The White House health aide has guided health policies in the president’s second term, including his executive order to pare back childhood vaccines.
[Premium Times] WHO explained that the transmission was interrupted through targeted vaccination campaigns, epidemiological investigations and expanded environmental surveillance.
Mumbai: Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with China-based Chongqing Chenan Biopharmaceutical for two insulin products in India.
